Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia (Q36024542)

11 August 2017

Gender, age, smoking behaviour and plasma clozapine concentrations in 193 Chinese inpatients with schizophrenia (English)

1 reference

11 August 2017

0 references

Philip B Mitchell

8

0 references

author name string

Yi-lang Tang

1

1 reference

11 August 2017

Peixian Mao

2

1 reference

11 August 2017

Feng-Min Li

3

1 reference

11 August 2017

Wenbiao Li

4

1 reference

11 August 2017

Qi Chen

5

1 reference

11 August 2017

Feng Jiang

6

1 reference

11 August 2017

Zhuo-ji Cai

7

1 reference

11 August 2017

language of work or name

English

0 references

publication date

12 February 2007

1 reference

British Journal of Clinical Pharmacology

11 August 2017

1 reference

11 August 2017

64

1 reference

11 August 2017

1

1 reference

11 August 2017

49-56

1 reference

Influence of dose, cigarette smoking, age, sex, and metabolic activity on plasma clozapine concentrations: a predictive model and nomograms to aid clozapine dose adjustment and to assess compliance in individual patients

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Smoking in patients receiving psychotropic medications: a pharmacokinetic perspective

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Effects of gender and age on plasma levels of clozapine and its metabolites: analyzed by critical statistics

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Pharmacokinetics of clozapine and its metabolites in psychiatric patients: plasma protein binding and renal clearance

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Population pharmacokinetics of clozapine evaluated with the nonparametric maximum likelihood method

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Clozapine--pharmacokinetic investigations and biochemical effects in man.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Clozapine: an atypical antipsychotic agent

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

The assay of clozapine and N-desmethylclozapine in human plasma by high-performance liquid chromatography

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Effect of treatment duration on plasma levels of clozapine and N-desmethylclozapine in men and women.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Determination of clozapine and its N-demethylated metabolite in plasma by use of gas chromatography-mass spectrometry with single ion detection

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Influence of patient-related variables on clozapine plasma levels.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Clozapine and norclozapine plasma concentrations and clinical response of treatment-refractory schizophrenic patients

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Antipsychotic efficacy in relation to plasma levels of clozapine (author's transl)

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Smoking and body weight influence the clearance of chlorpromazine

27 July 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02852.X

Relationship between patient variables and plasma clozapine concentrations: a dosing nomogram.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02852.X

Clozapine, norclozapine plasma levels, their sum and ratio in 50 psychotic patients: influence of patient-related variables

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02852.X

Gender differences in neuroleptic nonresponsive clozapine-treated schizophrenics.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2125.2007.02852.X

Repeated ingestion of grapefruit juice does not alter clozapine's steady-state plasma levels, effectiveness, and tolerability.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Treatment-resistance to clozapine in association with ultrarapid CYP1A2 activity and the C-->A polymorphism in intron 1 of the CYP1A2 gene: effect of grapefruit juice and low-dose fluvoxamine

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Serum levels of clozapine and norclozapine in patients treated with selective serotonin reuptake inhibitors

23 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Determination of clozapine, norclozapine, and clozapine-N-oxide in serum by liquid chromatography

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Clozapine and metabolites: concentrations in serum and clinical findings during treatment of chronically psychotic patients

21 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2000616

Clozapine serum concentrations are lower in smoking than in non-smoking schizophrenic patients

21 October 2018

1 reference

12 December 2020

Racial and gender differences in N-acetyltransferase, xanthine oxidase, and CYP1A2 activities

1 reference

12 December 2020

1 reference

12 December 2020

Determination of clozapine and its major metabolites in human serum using automated solid-phase extraction and subsequent isocratic high-performance liquid chromatography with ultraviolet detection

1 reference

12 December 2020

Relationship between clinical efficacy and clozapine concentrations in plasma in schizophrenia: effect of smoking

1 reference

12 December 2020

Clozapine response in treatment-refractory first-episode schizophrenia

1 reference

12 December 2020

Monitoring of plasma clozapine levels and its metabolites in refractory schizophrenic patients

1 reference

12 December 2020

Clozapine dosages and plasma drug concentrations

1 reference

12 December 2020

10.1111/J.1365-2125.2007.02852.X

Identifiers

DOI

1 reference

11 August 2017

1 reference

11 August 2017

1 reference